Functionally Defective High-Density Lipoprotein: A New Therapeutic Target at the Crossroads of Dyslipidemia, Inflammation, and Atherosclerosis

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Pharmacological Reviews

• Publication date

  2006-09-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1124/pr.58.3.1PMID 16968945
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Age-related decrease in high-density lipoproteins antioxidant activity is due to an alteration in the PON1's free sulfhydryl groups.

  2006cited by this paper
• HDL dysfunction in obstructive sleep apnea.

  2006cited by this paper
• Age-related decrease in high-density lipoproteins antioxidant activity is due to an alteration in the PON1's free sulfhydyl groups

  2006cited by this paper
• Structural modifications of HDL and functional consequences.

  2006cited by this paper
• Endothelial Dysfunction in Childhood Infection

  2005cited by this paper
• Serum Amyloid A and Lipoprotein Retention in Murine Models of Atherosclerosis

  2005influential reference
• Structure-reactivity studies of serum paraoxonase PON1 suggest that its native activity is lactonase.

  2005cited by this paper
• Clinical practice. Low HDL cholesterol levels.

  2005cited by this paper
• High-density lipoprotein inhibits migration of vascular smooth muscle cells through its sphingosine 1-phosphate component.

  2005cited by this paper
• A normotriglyceridemic, low HDL-cholesterol phenotype is characterised by elevated oxidative stress and HDL particles with attenuated antioxidative activity.

  2005influential reference
• High-Density Lipoproteins Induce Transforming Growth Factor-&bgr;2 Expression in Endothelial Cells

  2005cited by this paper
• ATVB in focus: redox mechanisms in blood vessels.

  2005cited by this paper
• D-4F and Statins Synergize to Render HDL Antiinflammatory in Mice and Monkeys and Cause Lesion Regression in Old Apolipoprotein E–Null Mice

  2005influential reference
• Defective antioxidative activity of small dense HDL3 particles in type 2 diabetes: relationship to elevated oxidative stress and hyperglycaemia

  2005influential reference
• Effects of atorvastatin versus other statins on fasting and postprandial C-reactive protein and lipoprotein-associated phospholipase A2 in patients with coronary heart disease versus control subjects.

  2005cited by this paper
• Acrolein Modifies Apolipoprotein A‐I in the Human Artery Wall

  2005influential reference
• Inflammation and Carotid Artery—Risk for Atherosclerosis Study (ICARAS)

  2005cited by this paper
• Association of cholesterol subfractions and carotid lipid core measured by MRI.

  2005cited by this paper
• Childhood infection and endothelial dysfunction: a potential link in atherosclerosis?

  2005cited by this paper
• High affinity, stability, and lactonase activity of serum paraoxonase PON1 anchored on HDL with ApoA-I.

  2005cited by this paper
• Localization of Nitration and Chlorination Sites on Apolipoprotein A-I Catalyzed by Myeloperoxidase in Human Atheroma and Associated Oxidative Impairment in ABCA1-dependent Cholesterol Efflux from Macrophages*

  2005influential reference
• Lipoproteomics II: Mapping of proteins in high‐density lipoprotein using two‐dimensional gel electrophoresis and mass spectrometry

  2005cited by this paper
• Neutrophils activation can be diminished by apolipoprotein A-I.

  2005cited by this paper
• Low HDL Cholesterol Levels

  2005cited by this paper
• High-density lipoproteins as therapeutic targets

  2005influential reference
• High-Density Lipoproteins Induce Transforming Growth Factor- (cid:1) 2 Expression in Endothelial Cells

  2005cited by this paper
• Rapid Communication Overexpression of Human Apolipoprotein A-II in Transgenic Mice Does Not Impair Macrophage-Specific Reverse Cholesterol Transport In Vivo

  2005influential reference
• Effects of bezafibrate on lipoprotein subclasses and inflammatory markers in patients with hypertriglyceridemia--a nuclear magnetic resonance study.

  2005cited by this paper
• Inflammatory Markers at the Site of Ruptured Plaque in Acute Myocardial Infarction: Locally Increased Interleukin-6 and Serum Amyloid A but Decreased C-Reactive Protein

  2005cited by this paper
• Inflammation, atherosclerosis, and coronary artery disease.

  2005cited by this paper
• Antibody against cholesteryl ester transfer protein (CETP) elicited by a recombinant chimeric enzyme vaccine attenuated atherosclerosis in a rabbit model.

  2005cited by this paper
• Very low density lipoproteins provide a vector for secretion of paraoxonase-1 from cells.

  2005cited by this paper
• ATVB in Focus Novel Approaches to the Treatment of Dyslipidemia

  2005cited by this paper
• ABCG1 Redistributes Cell Cholesterol to Domains Removable by High Density Lipoprotein but Not by Lipid-depleted Apolipoproteins*

  2005cited by this paper
• Acute inflammatory state during influenza infection and endothelial function.

  2005cited by this paper
• The atlas of heart disease and stroke

  2005cited by this paper
• Local Expression of Platelet-Activating Factor-Acetylhydrolase Reduces Accumulation of Oxidized Lipoproteins and Inhibits Inflammation, Shear Stress-Induced Thrombosis, and Neointima Formation in Balloon-Injured Carotid Arteries in Nonhyperlipidemic Rabbits

  2005cited by this paper
• Serum Amyloid A Is a Ligand for Scavenger Receptor Class B Type I and Inhibits High Density Lipoprotein Binding and Selective Lipid Uptake*

  2005cited by this paper
• ABCG1 has a critical role in mediating cholesterol efflux to HDL and preventing cellular lipid accumulation.

  2005cited by this paper
• Differential effects of HDL subpopulations on cellular ABCA1- and SR-BI-mediated cholesterol efflux Published, JLR Papers in Press, August 1, 2005. DOI 10.1194/jlr.M500187-JLR200

  2005cited by this paper
• Correlation of high density lipoprotein (HDL)-associated sphingosine 1-phosphate with serum levels of HDL-cholesterol and apolipoproteins.

  2005influential reference
• Insulin resistance and adiposity influence lipoprotein size and subclass concentrations. Results from the Insulin Resistance Atherosclerosis Study.

  2005cited by this paper
• Acrolein Impairs ABCA 1-dependent Cholesterol Export from Cells through Site-Specific Modification of Apolipoprotein A-I

  2005cited by this paper
• A mass spectrometric determination of the conformation of dimeric apolipoprotein A-I in discoidal high density lipoproteins.

  2005cited by this paper
• Consequences of cholesteryl ester transfer protein inhibition in patients with familial hypoalphalipoproteinemia.

  2005cited by this paper
• Differential effects of clusterin/apolipoprotein J on cellular growth and survival.

  2005cited by this paper
• Oral Small Peptides Render HDL Antiinflammatory in Mice and Monkeys and Reduce Atherosclerosis in ApoE Null Mice

  2005influential reference
• Tyrosine 192 in Apolipoprotein A-I Is the Major Site of Nitration and Chlorination by Myeloperoxidase, but Only Chlorination Markedly Impairs ABCA1-dependent Cholesterol Transport*

  2005cited by this paper
• The atlas of heart disease and stroke

  2005cited by this paper
• EFFECT OF POTENTIALLY MODIFIABLE RISK FACTORS ASSOCIATED WITH MYOCARDIAL INFARCTION IN 52 COUNTRIES (THE INTERHEART STUDY): CASE-CONTROL STUDY

  2005cited by this paper
• Impact of Short-Term Administration of High-Density Lipoproteins and Atorvastatin on Atherosclerosis in Rabbits

  2005influential reference
• Effect of Atorvastatin and Irbesartan, Alone and in Combination, on Postprandial Endothelial Dysfunction, Oxidative Stress, and Inflammation in Type 2 Diabetic Patients

  2005cited by this paper
• C-reactive protein comes of age

  2005cited by this paper
• Dyslipidemia and inflammation: an evolutionary conserved mechanism.

  2005influential reference
• Atheroprotective effects of high-density lipoprotein-associated lysosphingolipids.

  2005influential reference
• Oxidized Phospholipids Trigger Atherogenic Inflammation in Murine Arteries

  2005cited by this paper
• Serum Amyloid A Promotes Cholesterol Efflux Mediated by Scavenger Receptor B-I*

  2005cited by this paper
• Relationship between plasma lipid concentrations and HDL subclasses.

  2005cited by this paper
• Small high density lipoprotein subclasses: some of their physico-chemical properties and stability in solution.

  2005cited by this paper
• Hypertriglyceridemia is associated with preβ-HDL concentrations in subjects with familial low HDL Published, JLR Papers in Press, May 16, 2005. DOI 10.1194/jlr.M400480-JLR200

  2005cited by this paper
• High-density lipoprotein, but not low-density lipoprotein cholesterol levels influence short-term prognosis after acute coronary syndrome: results from the MIRACL trial.

  2005cited by this paper
• Compromised LCAT Function Is Associated With Increased Atherosclerosis

  2005influential reference
• An Oral ApoJ Peptide Renders HDL Antiinflammatory in Mice and Monkeys and Dramatically Reduces Atherosclerosis in Apolipoprotein E–Null Mice

  2005influential reference
• High-density lipoproteins attenuate interleukin-6 production in endothelial cells exposed to pro-inflammatory stimuli.

  2005cited by this paper
• Cholesteryl Ester Transfer Protein TaqIB Variant, High-Density Lipoprotein Cholesterol Levels, Cardiovascular Risk, and Efficacy of Pravastatin Treatment: Individual Patient Meta-Analysis of 13 677 Subjects

  2005cited by this paper
• Small, dense lipoprotein particles and reduced paraoxonase-1 in patients with the metabolic syndrome.

  2005influential reference
• High-density lipoproteins induce transforming growth factor-beta2 expression in endothelial cells.

  2005cited by this paper
• Inhibition of Lipopolysaccharide-Induced Inflammatory Responses by an Apolipoprotein AI Mimetic Peptide

  2005cited by this paper
• Nuclear Magnetic Resonance Lipoprotein Abnormalities in Prediabetic Subjects in the Insulin Resistance Atherosclerosis Study

  2005cited by this paper
• Fibrates and coronary risk reduction.

  2005cited by this paper
• Reconstituted High-Density Lipoproteins Inhibit the Acute Pro-Oxidant and Proinflammatory Vascular Changes Induced by a Periarterial Collar in Normocholesterolemic Rabbits

  2005influential reference
• Increased plasma lipid-poor apolipoprotein A-I in patients with coronary artery disease.

  2005cited by this paper
• Efficacy and safety of high-density lipoprotein cholesterol-increasing compounds: a meta-analysis of randomized controlled trials.

  2005influential reference
• Value of High-Density Lipoprotein (HDL) Subpopulations in Predicting Recurrent Cardiovascular Events in the Veterans Affairs HDL Intervention Trial

  2005influential reference
• Human paraoxonases (PON1, PON2, and PON3) are lactonases with overlapping and distinct substrate specificitiess⃞s⃞ The online version of this article (available at http://www.jlr.org) contains additional text, figures, and references. Published, JLR Papers in Press, March 16, 2005. DOI 10.1194/jlr.M

  2005cited by this paper
• Platelet-Activating Factor Acetylhydrolase Activity Indicates Angiographic Coronary Artery Disease Independently of Systemic Inflammation and Other Risk Factors: The Ludwigshafen Risk and Cardiovascular Health Study

  2005influential reference
• Effects of Cholesteryl Ester Transfer Protein Inhibition on High-Density Lipoprotein Subspecies, Apolipoprotein A-I Metabolism, and Fecal Sterol Excretion

  2005cited by this paper
• D-4F Induces Heme Oxygenase-1 and Extracellular Superoxide Dismutase, Decreases Endothelial Cell Sloughing, and Improves Vascular Reactivity in Rat Model of Diabetes

  2005cited by this paper
• Plasma Oxidized Low-Density Lipoprotein, a Strong Predictor for Acute Coronary Heart Disease Events in Apparently Healthy, Middle-Aged Men From the General Population

  2005influential reference
• Increased Atherosclerosis in Mice Lacking Apolipoprotein A-I Attributable to Both Impaired Reverse Cholesterol Transport and Increased Inflammation

  2005cited by this paper
• Paraoxonase-1 does not reduce or modify oxidation of phospholipids by peroxynitrite.

  2005cited by this paper
• Formation of dysfunctional high-density lipoprotein by myeloperoxidase.

  2005influential reference
• High-density lipoprotein antagonizes oxidized low-density lipoprotein by suppressing oxygen free-radical formation and preserving nitric oxide bioactivity.

  2005cited by this paper
• Acrolein Impairs ATP Binding Cassette Transporter A1-dependent Cholesterol Export from Cells through Site-specific Modification of Apolipoprotein A-I*

  2005influential reference
• Meta-Analysis: High-Dosage Vitamin E Supplementation May Increase All-Cause Mortality

  2005cited by this paper
• Modulation of paraoxonase (PON1) activity.

  2005influential reference
• Effectiveness of inhibition of cholesteryl ester transfer protein by JTT-705 in combination with pravastatin in type II dyslipidemia.

  2005cited by this paper
• Formation of methionine sulfoxide-containing specific forms of oxidized high-density lipoproteins.

  2005cited by this paper
• Apolipoprotein A-I mimetic peptides.

  2005cited by this paper
• Apolipoprotein E Mimetic Peptide Dramatically Lowers Plasma Cholesterol and Restores Endothelial Function in Watanabe Heritable Hyperlipidemic Rabbits

  2005cited by this paper
• Paraoxonase 1 (PON1) enhances HDL-mediated macrophage cholesterol efflux via the ABCA1 transporter in association with increased HDL binding to the cells: a possible role for lysophosphatidylcholine.

  2005influential reference
• Identification of Unique Lipoprotein Subclasses for Visceral Obesity by Component Analysis of Cholesterol Profile in High-Performance Liquid Chromatography

  2005cited by this paper
• Apolipoprotein E and atherosclerosis: beyond lipid effect.

  2004cited by this paper
• Corrigendum: Structure and evolution of the serum paraoxonase family of detoxifying and anti-atherosclerotic enzymes

  2004cited by this paper
• Effects of intravenous apolipoprotein A-I/phosphatidylcholine discs on paraoxonase and platelet-activating factor acetylhydrolase in human plasma and tissue fluid.

  2004cited by this paper
• HDL: a recipe for longevity.

  2004cited by this paper
• Quantification of Isoprostanes as Indices of Oxidant Stress and the Risk of Atherosclerosis in Humans

  2004cited by this paper
• Formation and Metabolism of Prebeta-Migrating, Lipid-Poor Apolipoprotein A-I

  2004cited by this paper
• Differential Effects of Apolipoprotein A-I–Mimetic Peptide on Evolving and Established Atherosclerosis in Apolipoprotein E-Null Mice

  2004cited by this paper
• Serum Lipid Levels and the Risk of Venous Thrombosis

  2004cited by this paper

• Protocol‐Dependent Effects of Transcutaneous Blood Systemic Photobiomodulation on Inflammatory, Metabolic, and Hemostatic Markers

  2026cites this paper
• Association between High-density lipoprotein cholesterol to apolipoprotein A-1 ratio and the outcome of ischemic stroke: A retrospective study.

  2026cites this paper
• HDL in Abdominal Aortic Aneurysm: Mechanistic Insight and Therapeutic Potential

  2026cites this paper
• The correlation between the uric acid to high-density lipoprotein cholesterol ratio and stroke

  2026cites this paper
• Environmental Factors and Lipid Metabolism in Atherosclerosis Development

  2026cites this paper
• Serum Interleukin-39 as an Emerging Inflammatory Biomarker in Diabetes Mellitus: Evidence from ROC Curve Analysis

  2026cites this paper
• Mechanisms, precision therapies, and technological frontiers in coronary atherosclerosis: a comprehensive review.

  2026cites this paper
• Effects of exercise combined with different dietary interventions on cardiovascular health a systematic review and network meta-analysis

  2025cites this paper
• Vitamin D immune modulation of the anti-inflammatory effects of HDL-associated proteins

  2025cites this paper
• Elevated high-density lipoprotein triglycerides increase atherosclerotic risk

  2025cites this paper
• Metal Transporter Gene SLC39A8 Polymorphism rs13107325 and Dietary Manganese Intake Are Associated with Measures of Cardiovascular Disease Risk in a UK Biobank Population Cohort

  2025cites this paper
• Lipoprotein subclasses and gastrointestinal cancers: novel perspectives and potential associations

  2025cites this paper
• The role of blood lipid and triglyceride‑glucose index in intracranial aneurysms: A retrospective study

  2025cites this paper
• Complex Metal Interaction Networks and the Mediating Role of Biological Aging in Dyslipidemia.

  2025cites this paper
• Importance of Genotype-Phenotype Correlation in the Population Screening of Familial Hypercholesterolemia

  2025cites this paper
• Oxidized high‐density lipoprotein associates with cardiometabolic dysfunction in coronary artery disease and acute coronary syndrome

  2025cites this paper
• Serum Tsukushi level is negatively associated with cholesterol efflux capacity in metabolic dysfunction-associated steatotic liver disease: a cross-sectional study

  2025cites this paper
• How can cholesterol efflux capacity be used as a risk factor for atherosclerotic cardiovascular disease?

  2025cites this paper
• ApoA-1 versus HDL-C as Markers of Cardiovascular Risk

  2025cites this paper
• A cross-sectional study investigating the L-shaped relationship between urinary albumin creatinine ratio and overweight/obesity in children and adolescents

  2025cites this paper
• Children with Post COVID-19 Multisystem Inflammatory Syndrome Display Unique Pathophysiological Metabolic Phenotypes

  2025cites this paper
• HDL meets triglyceride

  2025cites this paper
• Extremely high HDL cholesterol paradoxically increases the risk of all-cause mortality in non-diabetic males from the Korean population: Korean genome and epidemiology study-health examinees (KoGES-HEXA) cohorts

  2025cites this paper
• 心血管代谢因素与颅内动脉瘤的孟德尔随机化研究系统性文献分析

  2025cites this paper
• Protective role of apilarnil against intense exercise-induced liver injury in rats: serological and histopathological evidence

  2025cites this paper
• Frequency of low HDL-C levels in patients suffering from acute coronary syndrome.

  2025cites this paper
• Triglyceride-rich lipoproteins, remnants and atherosclerotic cardiovascular disease: What we know and what we need to know.

  2025cites this paper
• Dietary effects on the retina of hamsters

  2025cites this paper
• High-density lipoprotein cholesterol and kidney disease progression in patients with type 2 diabetes mellitus: the Fukushima Cohort Study

  2025cites this paper
• (Apo)Lipoprotein Profiling with Multi‐Omics Analysis Identified Medium‐HDL‐Targeting PSRC1 with Therapeutic Potential for Coronary Artery Disease

  2025cites this paper
• Reverse cholesterol transport: current assay methods, alterations with disease and response to therapeutic intervention

  2025cites this paper
• Lipid and brain volumetric measures in multiple sclerosis patients: findings from a large observational study

  2024cites this paper
• Understanding the heterogeneity and dysfunction of HDL in chronic kidney disease: insights from recent reviews

  2024cites this paper
• Association between monocyte to high-density lipoprotein cholesterol ratio and telomere length: based on NHANES 1999–2002

  2024cites this paper
• miR-223 accelerates lipid droplets clearance in microglia following spinal cord injury by upregulating ABCA1

  2024cites this paper
• The Relationship between Serum Urate and Aortic Aneurysm

  2024cites this paper
• Effect of selenium nanoparticle on lipid profile in local Awassi male lambs

  2024cites this paper
• Impact of metabolic-associated fatty liver disease on the cholesterol efflux capacity of high-density lipoproteins in adolescents with type 2 diabetes

  2024cites this paper
• ANGPTL3 is a novel HDL component that regulates HDL function

  2024cites this paper
• High-Density Lipoprotein-Associated Paraoxonase-1 (PON-1) and Scavenger Receptor Class B Type 1 (SRB-1) in Coronary Artery Disease: Correlation with Disease Severity

  2024cites this paper
• Impact of Exercise on High-Density Lipoprotein Cholesterol in Adults with Overweight and Obesity: A Narrative Review

  2024cites this paper
• Forecast of probable negative effects initiated by transformation of the proteomic profile of human blood plasma under combined exposure to chemicals

  2024cites this paper
• The Roles of Neutrophil-Derived Myeloperoxidase (MPO) in Diseases: The New Progress

  2024cites this paper
• The Association of the Levels of High-Density Lipoprotein and Apolipoprotein A1 with SARS-CoV-2 Infection and COVID-19 Severity: An Analysis of the N3C Database

  2023cites this paper
• Novel bioactive lipids enhanced HDL-mediated cholesterol efflux from macrophages through the ABCA1 receptor pathway.

  2023cites this paper
• Mechanistic insights into the anti-restenotic effects of HSP27 and HO1 modulated by reconstituted HDL on neointimal hyperplasia

  2023cites this paper
• ApoM binds endotoxin contributing to neutralization and clearance by High Density Lipoprotein

  2023cites this paper
• Independent, combine and interactive effects of heavy metal exposure on dyslipidemia biomarkers: A cross-sectional study in northeastern China.

  2023cites this paper
• Capacity of HDL to Efflux Cellular Cholesterol from Lipid-Loaded Macrophages Is Reduced in Patients with Familial Hypercholesterolemia

  2023cites this paper
• Low-Density Lipoprotein Cholesterol Is Not a Major Determinant of High-Sensitivity C-Reactive Protein Levels in People Without Known Diabetes Mellitus

  2023cites this paper
• Assessment of Ex Vivo Antioxidative Potential of Murine HDL in Atherosclerosis.

  2022cites this paper
• Relationships between Lipid-Related Metabolites and Age-Related Macular Degeneration Vary with Complement Genotype

  2022cites this paper
• Insulin Downregulates the Expression of ATP-binding Cassette Transporter A-I in Human Hepatoma Cell Line HepG2 in a FOXO1 and LXR Dependent Manner

  2022influential citation
• Effects of blood lipids and lipid‐modifying drugs on intracranial aneurysms

  2022cites this paper
• HDL and Therapy.

  2022cites this paper
• Post-Stroke Administration of L-4F Promotes Neurovascular and White Matter Remodeling in Type-2 Diabetic Stroke Mice

  2022cites this paper
• Lycopene-rich diets modulate HDL functionality and associated inflammatory markers without affecting lipoprotein size and distribution in moderately overweight, disease-free, middle-aged adults: A randomized controlled trial

  2022cites this paper
• Phosphatidylserine enhances anti‐inflammatory effects of reconstituted HDL in macrophages via distinct intracellular pathways

  2022cites this paper
• Protective Effects of Mirazid on Gentamicin-induced Nephrotoxicity in Rats through Antioxidant, Anti-inflammatory, JNK1/ iNOS, and Apoptotic Pathways; Novel Mechanistic Insights

  2022cites this paper
• Peptides as Therapeutic Agents for Atherosclerosis.

  2022cites this paper
• Angiogenin Levels and Their Association with Cardiometabolic Indices Following Vitamin D Status Correction in Saudi Adults

  2022cites this paper
• Low HDL Levels as a Major Risk Factor of Acute Myocardial Infarction in Pakistani Old Age Population

  2022cites this paper
• Combination of high‐density cholesterol level, elastic score, and severity of exocrine pancreatic dysfunction may be useful for a predictive factor for patients with early chronic pancreatitis

  2022cites this paper
• Changes in the Composition and Function of Lipoproteins after Bariatric Surgery in Patients with Severe Obesity

  2021cites this paper
• Functional Food and Bioactive Compounds on the Modulation of the Functionality of HDL-C: A Narrative Review

  2021cites this paper
• PPAR-Alpha Agonist Fenofibrate Combined with Octreotide Acetate in the Treatment of Acute Hyperlipidemia Pancreatitis

  2021cites this paper
• Fetal High-Density Lipoproteins: Current Knowledge on Particle Metabolism, Composition and Function in Health and Disease

  2021cites this paper
• Effect of Tocilizumab on LDL and HDL Characteristics in Patients with Rheumatoid Arthritis. An Observational Study

  2021cites this paper
• Dietary Strategies to Improve Cardiovascular Health: Focus on Increasing High-Density Lipoprotein Functionality

  2021cites this paper
• Sphingosine‐1‐phosphate as a key player of insulin secretion induced by high‐density lipoprotein treatment

  2021cites this paper
• High Density Lipoprotein Cholesterol Efflux Capacity and Atherosclerosis in Cardiovascular Disease: Pathophysiological Aspects and Pharmacological Perspectives

  2021cites this paper
• Reduction of small dense LDL and Il-6 after intervention with Plantago psyllium in adolescents with obesity: a parallel, double blind, randomized clinical trial

  2021cites this paper
• The Relationship Between Glycemic Control and Lipid Parameters in Turkish Patients with Non-Insulin-Dependent Diabetes Mellitus

  2021cites this paper
• The role of high-density lipoprotein cholesterol, apolipoprotein A and paraoxonase-1 in the pathophysiology of neuroprogressive disorders.

  2021cites this paper
• Exploring the Therapeutic Potential of the Bioinspired Reconstituted High Density Lipoprotein Nanostructures.

  2021cites this paper
• Prevalence, patterns and predictors of dyslipidaemia in Nigeria: a report from the REMAH study.

  2021cites this paper
• Moderate alcohol consumption and lipoprotein subfractions: a systematic review of intervention and observational studies.

  2021cites this paper
• Effects of lipoproteins on endothelial cells and macrophages function and its possible implications on fetal adverse outcomes associated to maternal hypercholesterolemia during pregnancy.

  2021cites this paper
• Different associations between HDL cholesterol and cardiovascular diseases in people with diabetes mellitus and people without diabetes mellitus: a prospective community-based study.

  2021cites this paper
• Effects of SNVs in ABCA1, ABCG1, ABCG5, ABCG8, and SCARB1 Genes on Plasma Lipids, Lipoproteins, and Adiposity Markers in a Brazilian Population

  2021cites this paper
• DMSO_A_327823 3711..3718

  2021cites this paper
• High-density lipoproteins (HDL): Novel function and therapeutic applications.

  2021cites this paper
• Is a High HDL-Cholesterol Level Always Beneficial?

  2021cites this paper
• Hepatic paraoxonase 1 ameliorates dysfunctional high-density lipoprotein and atherosclerosis in scavenger receptor class B type I deficient mice

  2021cites this paper
• DMSO_A_313006 2851..2862

  2021cites this paper
• Investigation of the Reference Interval Values of Fasting Plasma Glucose, Blood Pressure, and Blood Lipids in the Longevity People Aged 90 Years Old and Above

  2021cites this paper
• High-density lipoprotein: a double-edged sword in cardiovascular physiology and pathophysiology

  2021cites this paper
• Effect of Origanum dubium, Origanum vulgare subsp. hirtum, and Lavandula angustifolia essential oils on lipid profiles and liver biomarkers in athletes

  2021cites this paper
• HDL Dysfunctionality: Clinical Relevance of Quality Rather Than Quantity

  2021cites this paper
• A Non-Linear Association of High-Density Lipoprotein Cholesterol with All-Cause and Cause-Specific Mortality in Diabetic Patients

  2021cites this paper
• Antioxidant Properties of Anthocyanins and Their Mechanism of Action in Atherosclerosis.

  2021cites this paper
• Investigation of IgG anti-oxLDL antibody levels and HDL and LDL subclasses in patients with ST-segment elevation acute myocardial infarction

  2021cites this paper
• Efficacy and Safety of High-Density Lipoprotein/Apolipoprotein A1 Replacement Therapy in Humans and Mice With Atherosclerosis: A Systematic Review and Meta-Analysis

  2021cites this paper
• Dysfunctional High-Density Lipoproteins in Type 2 Diabetes Mellitus: Molecular Mechanisms and Therapeutic Implications

  2021cites this paper
• Proatherogenic Sialidases and Desialylated Lipoproteins: 35 Years of Research and Current State from Bench to Bedside

  2021cites this paper
• Obesity and severe coronavirus disease 2019: molecular mechanisms, paths forward, and therapeutic opportunities

  2021cites this paper
• Good Cholesterol Gone Bad? HDL and COVID-19

  2021cites this paper
• Characterization of the Cerebrospinal Fluid Proteome in Patients with Fragile X-Associated Tremor/Ataxia Syndrome

  2021cites this paper
• Antioxidant status in hypertensive disorders of pregnancy

  2021cites this paper
• Supramolecular copolymer modified statin-loaded discoidal rHDLs for atherosclerotic anti-inflammatory therapy by cholesterol efflux and M2 macrophage polarization.

  2021cites this paper